Enzastaurin in Combination of Capecitabine to Treat Breast Cancer
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: enzastaurin|DRUG: placebo|DRUG: capecitabine
Sponsor: Eli Lilly and Company